where will it go if there is new on COVID-19 trial tomorrow? You never know
CTI BioPharma Announces Enrollment of First Patient in COVID-19 PRE-VENT Phase 3 Clinical Trial- Company Expects to Report Topline Data by the End of 2020 -
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.